When cancer drug resistance meets metabolomics (bulk, single-cell and/or spatial): progress, potential, and perspective

HIGHLIGHTS

  • who: Zhiqiang Zhang and collaborators from the Longhua Hospital Shanghai University of Traditional Chinese Medicine, China have published the Article: When cancer drug resistance meets metabolomics (bulk, single-cell and/or spatial): Progress, potential, and perspective, in the Journal: (JOURNAL)
  • what: In the remaining sections of this review, the authors provide an indepth appraisal of the technologies and methods currently available for bulk, single-cell, and/or spatial metabolomics, and discuss how these latest advances have improved the understanding of mechanisms underlying the metabolic reprogramming in tumor responses to anticancer drugs. The aim is to . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?